DeepX Health is pleased to announce our new Head of Product, Dr. Laurens Kraal. Dr. Kraal recently served as a Research Fellow at the Berkeley Institute for Data Science. He has additional experience from his former position as Head of Product at a microbiome diagnostics company, and from being involved with multiple life-sciences start-ups. Dr. Kraal also has an impressive educational background, including a Ph. D. in Bioinformatics from UCSF.
Welcome to the team, Laurens!
DeepX Health’s DermoSight featured on BBCRead more
DeepX Health’s DermoSight at NHS event on 12 JulyRead more
DeepX Diagnostics Inc.'s DermoSight Receives FDA Clearance for Teledermatology Screening of Suspect Skin Cancer LesionsRead more
DeepX Health’s Skin Cancer Teledermoscopy Services Now in JerseyRead more
New Board Advisor to DeepX HealthRead more
DeepX Health selected to present at Nordic Life Science DaysRead more
Pharmacy Screening Demonstrates Great Efficiency and Potential for Cost ReductionsRead more
Primary Care Setting Pilot Launched with NHSRead more
DeepX Health to Present at the 8th World Congress of Teledermatology, Imaging and Artificial Intelligence for Skin DiseasesRead more
ScreenCancer Awarded Support for Diagnostic Triage Algorithm-ProjectRead more
DeepX Health to participate at the 7th Annual Dermatology Summit in San FranciscoRead more
DeepX Health to present at Digital Health World Congress in LondonRead more
DeepX Health participate in the DxPx ConferenceRead more
ScreenCancer approved for first round of Horizon 2020 programmeRead more